STOCK TITAN

LiveCare Continues Rapid Growth and Expansion into Key States

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
LiveCare, Inc. (OTC: LVCE) expands into key states and plans national expansion, targeting the USA diabetic market with 37 million diagnosed Type II diabetes and 97 million prediabetics. The company aims to credential with 10 states, potentially increasing the market from 8.5 million to 67.6 million. LiveCare's CEO, Max Rockwell, emphasizes the company's commitment to providing accessible, high-quality healthcare solutions and enhancing services to meet evolving healthcare needs.
Positive
  • None.
Negative
  • None.

Venice, FL, USA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- LiveCare, Inc. (OTC: LVCE), a leader in the telehealth industry, announces expansion into key states and ambitious expansion into national markets.

The USA diabetic market presents a vast opportunity for LiveCare, with 37 million Americans diagnosed with Type II diabetes and 97 million prediabetics. Initially licensed and credentialed only in Florida, LiveCare has now expanded to Texas, Ohio, and Michigan, tapping into a potential customer base of 27.4 million. Phase one of the company's expansion aims to credential with 10 states (California, Texas, Florida, Illinois, Michigan, New York, Georgia, Ohio, North Carolina, Maryland, South Carolina), representing half of the country's overall and diabetic population, potentially increasing the market from 8.5 million in Florida to 67.6 million by adding these additional states.

Max Rockwell, CEO of LiveCare, stated, "This significant growth in our daily member acquisitions and our expansion into key states is a testament to our commitment to providing accessible, high-quality healthcare solutions. We are not just expanding our business; we have created a company that truly helps people. We are excited to continue enhancing our services to meet the evolving healthcare needs, especially of the diabetic population."

LiveCare is in the final stages of expanding to these seven additional states, with the help of Bikham Health Care, a firm licensed in all 50 states with 18 years of experience, representing a further 40.2 million potential customers in addition to the 27.4 M potential patients we can now access. The company aims to expand nationwide upon completing phase one, significantly increasing its impact in the telehealth industry.

Stay tuned for more updates as LiveCare continues to broaden its services and impact in the healthcare industry.

Note: This press release contains forward-looking statements as defined by Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations and projections about future events and are subject to risks, uncertainties, and assumptions about LiveCare. Actual results may vary materially.

Contact Information: LIVECARE Phone: (800)-345-0491


FAQ

What is the ticker symbol for LiveCare, Inc.?

The ticker symbol for LiveCare, Inc. is LVCE.

What is the target market for LiveCare's expansion?

LiveCare is targeting the USA diabetic market with 37 million diagnosed Type II diabetes and 97 million prediabetics.

Which states has LiveCare expanded into?

LiveCare has expanded to Texas, Ohio, and Michigan, with plans to credential with 10 states including California, Texas, Florida, Illinois, Michigan, New York, Georgia, Ohio, North Carolina, Maryland, and South Carolina.

Who is assisting LiveCare in the expansion to additional states?

Bikham Health Care, a firm licensed in all 50 states with 18 years of experience, is assisting LiveCare in the expansion to seven additional states.

What is the ultimate goal of LiveCare's expansion?

The ultimate goal of LiveCare's expansion is to expand nationwide, significantly increasing its impact in the telehealth industry.

Livecare

OTC:LVCE

LVCE Rankings

LVCE Latest News

LVCE Stock Data

20.10M
32.23M